UiPath, Inc. $PATH Stake Increased by Corient Private Wealth LP

Key Points

• Corient Private Wealth LP increased its UiPath stake by 398.4% in the second quarter, adding 566,074 shares to own 708,146 shares valued at approximately $7.7 million. Institutional investors collectively hold 62.5% of PATH shares.
• UiPath insiders recently reduced their holdings: CEO Daniel Dines sold shares worth about $22.5 million, while COO Ashim Gupta sold approximately $1.6 million worth. Corporate insiders own 22.44% of the company.
• Analysts maintain a generally cautious outlook, with a consensus “Hold” rating and an average price target of $16.75. UiPath reported quarterly revenue of $410.26 million, up 13.3% year over year, and earnings of $0.15 per share.

Corient Private Wealth LP boosted its stake in UiPath, Inc. (NYSE:PATH - Free Report) by 398.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 708,146 shares of the company's stock after acquiring an additional 566,074 shares during the period. Corient Private Wealth LP owned 0.14% of UiPath worth $7,698,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in PATH. Trifecta Capital Advisors LLC bought a new position in shares of UiPath during the second quarter worth about $27,000. REAP Financial Group LLC acquired a new position in UiPath in the fourth quarter worth about $44,000. AdvisorNet Financial Inc grew its position in shares of UiPath by 750.0% in the 1st quarter. AdvisorNet Financial Inc now owns 3,400 shares of the company's stock worth $38,000 after acquiring an additional 3,000 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in shares of UiPath by 36.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 4,968 shares of the company's stock worth $81,000 after acquiring an additional 1,329 shares in the last quarter. Finally, Global Retirement Partners LLC bought a new stake in shares of UiPath in the 2nd quarter valued at approximately $57,000. 62.50% of the stock is currently owned by institutional investors.

Insider Activity at UiPath

In other news, CEO Daniel Dines sold 1,402,347 shares of the company's stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $16.07, for a total transaction of $22,535,716.29. Following the completion of the sale, the chief executive officer directly owned 26,491,238 shares of the company's stock, valued at $425,714,194.66. This represents a 5.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Ashim Gupta sold 117,339 shares of the business's stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $13.85, for a total value of $1,625,145.15. Following the sale, the chief operating officer owned 2,037,377 shares in the company, valued at approximately $28,217,671.45. The trade was a 5.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 22.44% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Weiss Ratings raised UiPath from a "hold (c-)" rating to a "hold (c)" rating in a research report on Wednesday, September 9th. Truist Financial upped their price objective on UiPath from $12.00 to $17.00 and gave the stock a "hold" rating in a research note on Friday, September 4th. BMO Capital Markets upped their target price on shares of UiPath from $13.00 to $18.00 and gave the stock a "market perform" rating in a research report on Friday, September 4th. TD Cowen raised their price target on shares of UiPath from $13.00 to $16.00 and gave the company a "hold" rating in a research note on Friday, September 4th. Finally, New Street Research set a $13.00 price target on shares of UiPath in a research note on Monday, June 1st. Three investment analysts have rated the stock with a Buy rating, sixteen have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $16.75.

UiPath Price Performance

PATH opened at $13.77 on Friday. The business has a 50 day moving average price of $14.39 and a two-hundred day moving average price of $12.16. UiPath, Inc. has a 1-year low of $9.20 and a 1-year high of $19.84. The company has a market capitalization of $7.14 billion, a price-to-earnings ratio of 20.56, a price-to-earnings-growth ratio of 1.33 and a beta of 1.02.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, September 3rd. The company reported $0.15 earnings per share for the quarter, meeting analysts' consensus estimates of $0.15. The company had revenue of $410.26 million during the quarter, compared to the consensus estimate of $397.77 million. UiPath had a net margin of 21.03% and a return on equity of 9.70%. UiPath's revenue was up 13.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.15 EPS. Equities analysts expect that UiPath, Inc. will post 0.47 EPS for the current fiscal year.

UiPath Profile

UiPath Inc NYSE: PATH develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.

The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.